Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood

Updated on: December 22,2023

Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood

Updated on:December 22,2023

Jumping genes for early detection of gastric cancer

by Braulio Valdebenito-MaturanaExample of a transposable element following cancer development on spatially resolved data. In green the normal epithelium, in brown the serrated lesion, and in red the t

Updated on: December 02,2024

Jumping genes for early detection of gastric cancer

by Braulio Valdebenito-MaturanaExample of a transposable element following cancer development on spatially resolved data. In green the normal epithelium, in brown the serrated lesion, and in red the t

Updated on:December 02,2024

Scientists develop new treatment with potential to tackle most common form of childhood cancer

Updated on: June 14,2025

Scientists develop new treatment with potential to tackle most common form of childhood cancer

Updated on:June 14,2025

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on: May 26,2024

Significant proportion of cancer drugs lack proof of added benefit, finds study

by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved

Updated on:May 26,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on: June 17,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on:June 17,2024

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on: December 02,2024

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on:December 02,2024

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on: February 18,2024

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on:February 18,2024

Why researchers use zebrafish to study a cancer-linked inflammation pathway

byMemorial Sloan Kettering Cancer CenterGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2022.111974In science, how you ask a question is often as important as wh

Updated on: January 08,2024

Why researchers use zebrafish to study a cancer-linked inflammation pathway

byMemorial Sloan Kettering Cancer CenterGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2022.111974In science, how you ask a question is often as important as wh

Updated on:January 08,2024

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa

Updated on: December 25,2023

AI with infrared imaging enables precise colon cancer diagnostics

byRuhr-Universitaet-BochumGraphical abstract. Credit:European Journal of Cancer(2023). DOI: 10.1016/j.ejca.2022.12.026The immense progress in the field of therapy options over the pa

Updated on:December 25,2023

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor

Updated on: January 26,2024

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor

Updated on:January 26,2024

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J

Updated on: January 26,2024

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J

Updated on:January 26,2024

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on: April 22,2024

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on:April 22,2024